<DOC>
	<DOCNO>NCT02030548</DOCNO>
	<brief_summary>The aim study evaluate surgery-related bleeding mortality patient need acute coronary artery bypass graft without valve replacement dual antiplatelet therapy aspirin P2Y12 receptor blocker ( Clopidogrel , Prasugrel , Ticagrelor )</brief_summary>
	<brief_title>Bleeding Patients Undergoing CABG During Dual Antiplatelet Therapy</brief_title>
	<detailed_description />
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>consecutive patient undergo acute CABG without valve replacement within 48 hour last intake dual antiplatelet therapy concomitant oral anticoagulant dialysis surgery employ hypothermic cardiac arrest</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>CABG</keyword>
	<keyword>dual antiplatelet therapy</keyword>
	<keyword>aspirin</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>prasugrel</keyword>
	<keyword>ticagrelor</keyword>
</DOC>